Long-term safety of tiotropium delivered by Respimat® SoftMist™ Inhaler: patient selection and special considerations
Ching Kuo Tan, Gui Quan Say, James B Geake Department of Respiratory Medicine, Lyell McEwin Hospital, Elizabeth Vale, SA, Australia Abstract: Tiotropium bromide is a long-acting inhaled muscarinic antagonist used in patients with chronic respiratory disease. It has been available since 2002 as a sin...
Saved in:
Main Authors: | Tan CK (Author), Say GQ (Author), Geake JB (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Tiotropium Soft Mist Inhalers on Dynamic Changes in Lung Mechanics of Patients with Chronic Obstructive Pulmonary Disease Receiving Mechanical Ventilation: A Prospective Pilot Study
by: Pin-Kuei Fu, et al.
Published: (2020) -
Use of Artelon® Cosmetic in soft tissue augmentation in dentistry
by: Ko YK, et al.
Published: (2011) -
Preparation and Evaluation of Mucus-Penetrating Inhalable Microparticles of Tiotropium Bromide Containing Sodium Glycocholate
by: Yong-Bin Kwon, et al.
Published: (2022) -
Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial
by: Mustafa Erelel, et al.
Published: (2021) -
The People of the Mist
by: Haggard, H. Rider (Henry Rider), 1856-1925